These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 12680218)
21. Rifampicin inhibits the retinal neovascularization in vitro and in vivo. Chikaraishi Y; Matsunaga N; Shimazawa M; Hara H Exp Eye Res; 2008 Jan; 86(1):131-7. PubMed ID: 18031740 [TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance. Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678 [TBL] [Abstract][Full Text] [Related]
23. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Seng WL; Eng K; Lee J; McGrath P Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079 [TBL] [Abstract][Full Text] [Related]
24. [Study on the effects of curcumin on angiogenesis]. Gao C; Ding Z; Liang B; Chen N; Cheng D Zhong Yao Cai; 2003 Jul; 26(7):499-502. PubMed ID: 14650061 [TBL] [Abstract][Full Text] [Related]
25. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Forooghian F; Das B Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204 [TBL] [Abstract][Full Text] [Related]
26. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Cao QZ; Lin ZB Acta Pharmacol Sin; 2004 Jun; 25(6):833-8. PubMed ID: 15169641 [TBL] [Abstract][Full Text] [Related]
27. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Polverino A; Coxon A; Starnes C; Diaz Z; DeMelfi T; Wang L; Bready J; Estrada J; Cattley R; Kaufman S; Chen D; Gan Y; Kumar G; Meyer J; Neervannan S; Alva G; Talvenheimo J; Montestruque S; Tasker A; Patel V; Radinsky R; Kendall R Cancer Res; 2006 Sep; 66(17):8715-21. PubMed ID: 16951187 [TBL] [Abstract][Full Text] [Related]
28. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis. Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657 [TBL] [Abstract][Full Text] [Related]
29. Effect of human Angiostatin protein on human angiogenesis in vitro. Jung SP; Siegrist B; Wang YZ; Wade MR; Anthony CT; Hornick C; Woltering EA Angiogenesis; 2003; 6(3):233-40. PubMed ID: 15041799 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Ito Y; Oike Y; Yasunaga K; Hamada K; Miyata K; Matsumoto S; Sugano S; Tanihara H; Masuho Y; Suda T Cancer Res; 2003 Oct; 63(20):6651-7. PubMed ID: 14583458 [TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice? Mancuso A; Sternberg CN Crit Rev Oncol Hematol; 2005 Jul; 55(1):67-81. PubMed ID: 15890525 [TBL] [Abstract][Full Text] [Related]
33. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation. Yamada J; Tsuno NH; Kitayama J; Tsuchiya T; Yoneyama S; Asakage M; Okaji Y; Shuno Y; Nishikawa T; Tanaka J; Takahashi K; Nagawa H J Surg Res; 2009 Jan; 151(1):115-20. PubMed ID: 18619615 [TBL] [Abstract][Full Text] [Related]
34. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Toi M; Bando H; Ramachandran C; Melnick SJ; Imai A; Fife RS; Carr RE; Oikawa T; Lansky EP Angiogenesis; 2003; 6(2):121-8. PubMed ID: 14739618 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Piao M; Mori D; Satoh T; Sugita Y; Tokunaga O Endothelium; 2006; 13(4):249-66. PubMed ID: 16990182 [TBL] [Abstract][Full Text] [Related]
36. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Kong D; Okamura M; Yoshimi H; Yamori T Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509 [TBL] [Abstract][Full Text] [Related]
37. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
38. Anti-angiogenic function of tocotrienol. Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349 [TBL] [Abstract][Full Text] [Related]
39. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068 [TBL] [Abstract][Full Text] [Related]
40. 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2. Cryan LM; Bazinet L; Habeshian KA; Cao S; Clardy J; Christensen KA; Rogers MS J Med Chem; 2013 Mar; 56(5):1940-5. PubMed ID: 23394144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]